Skip to main content Accessibility help
×
Hostname: page-component-76fb5796d-qxdb6 Total loading time: 0 Render date: 2024-04-28T07:41:30.854Z Has data issue: false hasContentIssue false

Chapter 21 - Sclerosing cholangitis

from Section III - Hepatitis and immune disorders

Published online by Cambridge University Press:  05 March 2014

Alexander G. Miethke
Affiliation:
Division of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, University of Cincinnati College of Medicine, and Pediatric Liver Care Center, Children’s Hospital Medical Center, Cincinnati, OH, USA
William F. Balistreri
Affiliation:
University of Cincinnati College of Medicine
Frederick J. Suchy
Affiliation:
University of Colorado Medical Center
Ronald J. Sokol
Affiliation:
University of Colorado Medical Center
William F. Balistreri
Affiliation:
University of Cincinnati College of Medicine
Get access

Summary

Introduction

There is a wide spectrum of etiologically obscure inflammatory disorders of the biliary tract, including the obstructive cholangiopathies that occur in infancy (biliary atresia and related entities), primary biliary cirrhosis, which is noted in adults, and primary sclerosing cholangitis (PSC), which may affect patients of all age groups, particularly those with chronic inflammatory bowel disease (IBD). These hepatobiliary disorders differ markedly in clinical expression but display substantial overlap in morphologic features, suggesting that their pathogenesis may be shared. Because the intra- and extrahepatic biliary tree may be assumed to possess a limited repertoire of reactions to injury caused by various inflammatory mechanisms, the association of PSC and IBD may provide insight into other forms of “cholangitis.” The frequency of this association also presents an opportunity to trace the evolution of PSC. This chapter focuses on idiopathic forms of sclerosing cholangitis in children, the PSC–IBD complex, and related disorders.

Definition

Sclerosing cholangitis is a chronic hepatobiliary disorder characterized by inflammation of the intra- and/or extrahepatic ducts, leading to focal dilatation, narrowing, or obliteration accompanied by local periductular fibrosis. Progressive, obliterative fibrosis usually leads to biliary cirrhosis and end-stage liver disease. The structural abnormalities of larger bile ducts are best appreciated by cholangiography, which in most cases is essential in establishing the diagnosis. However, careful delineation of the histology of the hepatic parenchyma and smaller intrahepatic ducts may also suggest the diagnosis.

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2014

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Mieli-Vergani, G, Vergani, D. Unique features of primary sclerosing cholangitis in children. Curr Opin Gastroenterol 2010;26:265–268.CrossRefGoogle ScholarPubMed
Batres, LA, Russo, P, Mathews, M, et al. Primary sclerosing cholangitis in children: a histologic follow-up study. Pediatr Dev Pathol 2005;8:568–576.CrossRefGoogle ScholarPubMed
Debray, D, Pariente, D, Urvoas, E, Hadchouel, M, Bernard, O. Sclerosing cholangitis in children. J Pediatr 1994;124:49–56.CrossRefGoogle ScholarPubMed
El-Shabrawi, M, Wilkinson, ML, Portmann, B, et al. Primary sclerosing cholangitis in childhood. Gastroenterology 1987;92(5 Pt 1):1226–1235.CrossRefGoogle ScholarPubMed
Feldstein, AE, Perrault, J, El-Youssif, M, et al. Primary sclerosing cholangitis in children: a long-term follow-up study. Hepatology 2003;38:210–217.CrossRefGoogle ScholarPubMed
Gregorio, GV, Portmann, B, Karani, J, et al. Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study. Hepatology 2001;33:544–553.CrossRefGoogle ScholarPubMed
Miloh, T, Arnon, R, Shneider, B, Suchy, F, Kerkar, N. A retrospective single-center review of primary sclerosing cholangitis in children. Clin Gastroenterol Hepatol 2009;7:239–245.CrossRefGoogle ScholarPubMed
Sisto, A, Feldman, P, Garel, L, et al. Primary sclerosing cholangitis in children: study of five cases and review of the literature. Pediatrics 1987;80:918–923.Google ScholarPubMed
Wilschanski, M, Chait, P, Wade, JA, et al. Primary sclerosing cholangitis in 32 children: clinical, laboratory, and radiographic features, with survival analysis. Hepatology 1995;22:1415–1422.Google ScholarPubMed
Amedee-Manesme, O, Bernard, O, Brunelle, F, et al. Sclerosing cholangitis with neonatal onset. J Pediatr 1987;111:225–229.CrossRefGoogle ScholarPubMed
Shanmugam, NP, Harrison, PM, Devlin, J, et al. Selective use of endoscopic retrograde cholangiopancreatography in the diagnosis of biliary atresia in infants younger than 100 days. J Pediatr Gastroenterol Nutr 2009;49:435–441.CrossRefGoogle Scholar
Floreani, A, Rizzotto, ER, Ferrara, F, et al. Clinical course and outcome of autoimmune hepatitis/primary sclerosing cholangitis overlap syndrome. Am J Gastroenterol 2005;100:1516–1522.CrossRefGoogle ScholarPubMed
Loftus, EV, Harewood, GC, Loftus, CG, et al. PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis. Gut 2005;54:91–96.CrossRefGoogle ScholarPubMed
Lindor, KD, Kowdley, KV, Luketic, VA, et al. High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis. Hepatology 2009;50:808–814.CrossRefGoogle ScholarPubMed
Kaplan, GG, Laupland, KB, Butzner, D, Urbanski, SJ, Lee, SS. The burden of large and small duct primary sclerosing cholangitis in adults and children: a population-based analysis. Am J Gastroenterol 2007;102:1042–1049.CrossRefGoogle ScholarPubMed
Tischendorf, JJ, Hecker, H, Kruger, M, Manns, MP, Meier, PN. Characterization, outcome, and prognosis in 273 patients with primary sclerosing cholangitis: A single center study. Am J Gastroenterol 2007;102:107–114.CrossRefGoogle ScholarPubMed
Bambha, K, Kim, WR, Talwalkar, J, et al. Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community. Gastroenterology 2003;125:1364–1369.CrossRefGoogle Scholar
Card, TR, Solaymani-Dodaran, M, West, J. Incidence and mortality of primary sclerosing cholangitis in the UK: a population-based cohort study. J Hepatol 2008;48:939–944.CrossRefGoogle ScholarPubMed
Fausa, O, Schrumpf, E, Elgjo, K. Relationship of inflammatory bowel disease and primary sclerosing cholangitis. Semin Liver Dis 1991;11:31–39.CrossRefGoogle ScholarPubMed
Olsson, R, Danielsson, A, Jarnerot, G, et al. Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis. Gastroenterology 1991;100(5 Pt 1):1319–1323.CrossRefGoogle ScholarPubMed
Faubion, WA, Loftus, EV, Sandborn, WJ, Freese, DK, Perrault, J. Pediatric “PSC-IBD”: a descriptive report of associated inflammatory bowel disease among pediatric patients with PSC. J Pediatr Gastroenterol Nutr 2001;33:296–300.CrossRefGoogle ScholarPubMed
Sano, H, Nakazawa, T, Ando, T, et al. Clinical characteristics of inflammatory bowel disease associated with primary sclerosing cholangitis. J Hepatobiliary Pancreat Sci 2011;18:154–161.CrossRefGoogle ScholarPubMed
Ponsioen, CY, Vrouenraets, SM, Prawirodirdjo, W, et al. Natural history of primary sclerosing cholangitis and prognostic value of cholangiography in a Dutch population. Gut 2002;51:562–566.CrossRefGoogle Scholar
Hyams, JS, Treem, WR, Justinich, CJ, et al. Characterization of symptoms in children with recurrent abdominal pain: resemblance to irritable bowel syndrome. J Pediatr Gastroenterol Nutr 1995;20:209–214.CrossRefGoogle ScholarPubMed
Farkkila, M, Karvonen, AL, Nurmi, H, et al. Metronidazole and ursodeoxycholic acid for primary sclerosing cholangitis: a randomized placebo-controlled trial. Hepatology 2004;40:1379–1386.CrossRefGoogle ScholarPubMed
MacCarty, RL, LaRusso, NF, Wiesner, RH, Ludwig, J. Primary sclerosing cholangitis: findings on cholangiography and pancreatography. Radiology 1983;149:39–44.CrossRefGoogle ScholarPubMed
LaRusso, NF, Wiesner, RH, Ludwig, J, MacCarty, RL. Current concepts. Primary sclerosing cholangitis. N Engl J Med 1984;310:899–903.CrossRefGoogle ScholarPubMed
Majoie, CB, Reeders, JW, Sanders, JB, Huibregtse, K, Jansen, PL. Primary sclerosing cholangitis: a modified classification of cholangiographic findings. AJR Am J Roentgenol 1991;157:495–497.CrossRefGoogle ScholarPubMed
Dave, M, Elmunzer, BJ, Dwamena, BA, Higgins, PD. Primary sclerosing cholangitis: meta-analysis of diagnostic performance of MR cholangiopancreatography. Radiology 2010;256:387–396.CrossRefGoogle ScholarPubMed
Ferrara, C, Valeri, G, Salvolini, L, Giovagnoni, A. Magnetic resonance cholangiopancreatography in primary sclerosing cholangitis in children. Pediatr Radiol 2002;32:413–417.CrossRefGoogle ScholarPubMed
Chavhan, GB, Roberts, E, Moineddin, R, Babyn, PS, Manson, DE. Primary sclerosing cholangitis in children: utility of magnetic resonance cholangiopancreatography. Pediatr Radiol 2008;38:868–873.CrossRefGoogle ScholarPubMed
Angulo, P, Peter, JB, Gershwin, ME, et al. Serum autoantibodies in patients with primary sclerosing cholangitis. J Hepatol 2000;32:182–187.CrossRefGoogle ScholarPubMed
Mendes, FD, Jorgensen, R, Keach, J, et al. Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis. Am J Gastroenterol 2006;101:2070–2075.CrossRefGoogle ScholarPubMed
Ludwig, J. Surgical pathology of the syndrome of primary sclerosing cholangitis. Am J Surg Pathol 1989;13(Suppl 1):43–49.Google ScholarPubMed
Bjornsson, E, Boberg, KM, Cullen, S, et al. Patients with small duct primary sclerosing cholangitis have a favourable long term prognosis. Gut 2002;51:731–735.CrossRefGoogle ScholarPubMed
Broome, U, Glaumann, H, Lindstom, E, et al. Natural history and outcome in 32 Swedish patients with small duct primary sclerosing cholangitis (PSC). J Hepatol 2002;36:586–589.CrossRefGoogle Scholar
Grant, AJ, Lalor, PF, Salmi, M, Jalkanen, S, Adams, DH. Homing of mucosal lymphocytes to the liver in the pathogenesis of hepatic complications of inflammatory bowel disease. Lancet 2002;359:150–157.CrossRefGoogle ScholarPubMed
Lichtman, SN, Keku, J, Clark, RL, Schwab, JH, Sartor, RB. Biliary tract disease in rats with experimental small bowel bacterial overgrowth. Hepatology 1991;13:766–772.CrossRefGoogle ScholarPubMed
Fickert, P, Fuchsbichler, A, Wagner, M, et al. Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice. Gastroenterology 2004;127:261–274.CrossRefGoogle ScholarPubMed
Karlsen, TH, Franke, A, Melum, E, et al. Genome-wide association analysis in primary sclerosing cholangitis. Gastroenterology 2010;138:1102–1111.CrossRefGoogle ScholarPubMed
Hov, JR, Kosmoliaptsis, V, Traherne, JA, et al. Electrostatic modifications of the human leukocyte antigen-DR P9 peptide-binding pocket and susceptibility to primary sclerosing cholangitis. Hepatology 2011;53:1967–1976.CrossRefGoogle ScholarPubMed
Donaldson, PT. Genetics of liver disease: immunogenetics and disease pathogenesis. Gut 2004;53:599–608.CrossRefGoogle ScholarPubMed
Hov, JR, Keitel, V, Laerdahl, JK, et al. Mutational characterization of the bile acid receptor TGR5 in primary sclerosing cholangitis. PLoS One 2010;5:e12403.CrossRefGoogle ScholarPubMed
Xu, B, Broome, U, Ericzon, BG, Sumitran-Holgersson, S. High frequency of autoantibodies in patients with primary sclerosing cholangitis that bind biliary epithelial cells and induce expression of CD44 and production of interleukin 6. Gut 2002;51:120–127.CrossRefGoogle ScholarPubMed
Eksteen, B, Grant, AJ, Miles, A, et al. Hepatic endothelial CCL25 mediates the recruitment of CCR9+ gut-homing lymphocytes to the liver in primary sclerosing cholangitis. J Exp Med 2004;200:1511–1517.CrossRefGoogle ScholarPubMed
Koga, H, Sakisaka, S, Yoshitake, M, et al. Abnormal accumulation in lipopolysaccharide in biliary epithelial cells of rats with self-filling blind loop. Int J Mol Med 2002;9:621–626.Google ScholarPubMed
Numata, Y, Tazuma, S, Nishioka, T, Ueno, Y, Chayama, K. Immune response in mouse experimental cholangitis associated with colitis induced by dextran sulfate sodium. J Gastroenterol Hepatol 2004;19:910–915.CrossRefGoogle ScholarPubMed
Fickert, P, Fuchsbichler, A, Marschall, HU, et al. Lithocholic acid feeding induces segmental bile duct obstruction and destructive cholangitis in mice. Am J Pathol 2006;168:410–422.CrossRefGoogle ScholarPubMed
Fiorotto, R, Scirpo, R, Trauner, M, et al. Loss of CFTR affects biliary epithelium innate immunity and causes TLR4-NF-kappaB-mediated inflammatory response in mice. Gastroenterology 2011;141:1498–508, 508 e1–5.CrossRefGoogle ScholarPubMed
Trauner, M, Fickert, P, Baghdasaryan, A, et al. New insights into autoimmune cholangitis through animal models. Dig Dis 2010;28:99–104.CrossRefGoogle ScholarPubMed
Lindor, KD. Ursodiol for primary sclerosing cholangitis. Mayo Primary Sclerosing Cholangitis–Ursodeoxycholic Acid Study Group. N Engl J Med 1997;336:691–695.CrossRefGoogle ScholarPubMed
Olsson, R, Boberg, KM, de Muckadell, OS, et al. High-dose ursodeoxycholic acid in primary sclerosing cholangitis: a 5-year multicenter, randomized, controlled study. Gastroenterology 2005;129:1464–1472.CrossRefGoogle ScholarPubMed
Imam, MH, Sinakos, E, Gossard, AA, et al. High-dose ursodeoxycholic acid increases risk of adverse outcomes in patients with early stage primary sclerosing cholangitis. Aliment Pharmacol Ther 2011;34:1185–1192.CrossRefGoogle ScholarPubMed
Chapman, R, Fevery, J, Kalloo, A, et al. Diagnosis and management of primary sclerosing cholangitis. Hepatology 2010;51:660–678.CrossRefGoogle ScholarPubMed
Davies, YK, Cox, KM, Abdullah, BA, et al. Long-term treatment of primary sclerosing cholangitis in children with oral vancomycin: an immunomodulating antibiotic. J Pediatr Gastroenterol Nutr 2008;47:61–67.CrossRefGoogle ScholarPubMed
Beuers, U, Kullak-Ublick, GA, Pusl, T, Rauws, ER, Rust, C. Medical treatment of primary sclerosing cholangitis: a role for novel bile acids and other (post-)transcriptional modulators?Clin Rev Allergy Immunol 2009;36:52–61.CrossRefGoogle ScholarPubMed
Ibrahim, SH, Lindor, KD. Current management of primary sclerosing cholangitis in pediatric patients. Paediatr Drugs 2011;13:87–95.CrossRefGoogle ScholarPubMed
Miloh, T, Anand, R, Yin, W, et al. Pediatric liver transplantation for primary sclerosing cholangitis. Liver Transplant 2011;17:925–933.CrossRefGoogle ScholarPubMed
Damrah, O, Sharma, D, Burroughs, A, et al. Duct-to-duct biliary reconstruction in orthotopic liver transplantation for primary sclerosing cholangitis: a viable and safe alternative. Transplant Int 2012;25:64–68.CrossRefGoogle ScholarPubMed
Joshi, D, Bjarnason, I, Belgaumkar, A, et al. The impact of inflammatory bowel disease post-liver transplantation for primary sclerosing cholangitis. Liver Int 2013;33:53–61.CrossRefGoogle ScholarPubMed
Wiesner, RH, Grambsch, PM, Dickson, ER, et al. Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis. Hepatology 1989;10:430–436.CrossRefGoogle ScholarPubMed
Graziadei, IW. Recurrence of primary sclerosing cholangitis after liver transplantation. Liver Transplant 2002;8:575–581.CrossRefGoogle ScholarPubMed
Vera, A, Moledina, S, Gunson, B, et al. Risk factors for recurrence of primary sclerosing cholangitis of liver allograft. Lancet 2002;360:1943–1944.CrossRefGoogle ScholarPubMed
Boberg, KM, Rocca, G, Egeland, T, et al. Time-dependent Cox regression model is superior in prediction of prognosis in primary sclerosing cholangitis. Hepatology 2002;35:652–657.CrossRefGoogle ScholarPubMed
Burak, K, Angulo, P, Pasha, TM, et al. Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis. Am J Gastroenterol 2004;99:523–526.CrossRefGoogle ScholarPubMed
Ross, AM, Anupindi, SA, Balis, UJ. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 11-2003. A 14-year-old boy with ulcerative colitis, primary sclerosing cholangitis, and partial duodenal obstruction. N Engl J Med 2003;348:1464–1476.CrossRefGoogle ScholarPubMed
Vera, A, Gunson, BK, Ussatoff, V, et al. Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis. Transplantation 2003;75:1983–1988.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • Sclerosing cholangitis
    • By Alexander G. Miethke, Division of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, University of Cincinnati College of Medicine, and Pediatric Liver Care Center, Children’s Hospital Medical Center, Cincinnati, OH, USA, William F. Balistreri, University of Cincinnati College of Medicine
  • Edited by Frederick J. Suchy, University of Colorado Medical Center, Ronald J. Sokol, University of Colorado Medical Center, William F. Balistreri
  • Book: Liver Disease in Children
  • Online publication: 05 March 2014
  • Chapter DOI: https://doi.org/10.1017/CBO9781139012102.022
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • Sclerosing cholangitis
    • By Alexander G. Miethke, Division of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, University of Cincinnati College of Medicine, and Pediatric Liver Care Center, Children’s Hospital Medical Center, Cincinnati, OH, USA, William F. Balistreri, University of Cincinnati College of Medicine
  • Edited by Frederick J. Suchy, University of Colorado Medical Center, Ronald J. Sokol, University of Colorado Medical Center, William F. Balistreri
  • Book: Liver Disease in Children
  • Online publication: 05 March 2014
  • Chapter DOI: https://doi.org/10.1017/CBO9781139012102.022
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • Sclerosing cholangitis
    • By Alexander G. Miethke, Division of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, University of Cincinnati College of Medicine, and Pediatric Liver Care Center, Children’s Hospital Medical Center, Cincinnati, OH, USA, William F. Balistreri, University of Cincinnati College of Medicine
  • Edited by Frederick J. Suchy, University of Colorado Medical Center, Ronald J. Sokol, University of Colorado Medical Center, William F. Balistreri
  • Book: Liver Disease in Children
  • Online publication: 05 March 2014
  • Chapter DOI: https://doi.org/10.1017/CBO9781139012102.022
Available formats
×